JTE 7-31

JTE 7-31
	IUPAC name 2-[2-(4-hydroxyphenyl)ethyl]-5-methoxy-4-(pentylamino)-2,3-dihydro-1H-isoindol-1-one
Identifiers
CAS number	194358-72-0
PubChem	19363402
ChemSpider	13767708
Jmol-3D images	Image 1
	SMILES Oc1ccc(cc1)CCN3Cc2c(ccc(OC)c2NCCCCC)C3=O ;
	InChI InChI=1S/C22H28N2O3/c1-3-4-5-13-23-21-19-15-24(14-12-16-6-8-17(25)9-7-16)22(26)18(19)10-11-20(21)27-2/h6-11,23,25H,3-5,12-15H2,1-2H3 ; Key: FMUMUYFMLZGXJR-UHFFFAOYSA-N InChI=1/C22H28N2O3/c1-3-4-5-13-23-21-19-15-24(14-12-16-6-8-17(25)9-7-16)22(26)18(19)10-11-20(21)27-2/h6-11,23,25H,3-5,12-15H2,1-2H3; Key: FMUMUYFMLZGXJR-UHFFFAOYAA ;
Properties
Molecular formula	C22H28N2O3
Molar mass	368.469
	(verify) (what is: /?); Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
	Infobox references

From Wikipedia, the free encyclopedia

Jump to: navigation, search

JTE 7-31 is a selective cannabinoid receptor agonist invented by Japan Tobacco.^[1]^[2] It is a reasonably highly selective CB₂ agonist, but still retains appreciable affinity at CB₁, with a K_i of 0.088nM at CB₂ vs 11nM at CB₁.

[edit] See also

[edit] References

^ WO patent 1997/029079, Inaba T, Kaya T, Iwamura H, "Novel compounds and pharmaceutical use thereof", granted 1997-14-08
^ US patent 6017919, Inaba T, Kaya T, Iwamura H, "Compounds and pharmaceutical use thereof", granted 2000-01-25

This cannabinoid related article is a stub. You can help Wikipedia by expanding it.

[WO_1997.2F029079-0] WO patent 1997/029079, Inaba T, Kaya T, Iwamura H, "Novel compounds and pharmaceutical use thereof", granted 1997-14-08

[US_6017919-1] US patent 6017919, Inaba T, Kaya T, Iwamura H, "Compounds and pharmaceutical use thereof", granted 2000-01-25

[1]

[2]

Jan	FEB	Mar
	24
2011	2012	2013

JTE 7-31

[edit] See also

[edit] References

Personal tools

Namespaces

Variants

Views

Actions

Search

Navigation

Interaction

Toolbox

Print/export